Elleaume H, Charvet A M, Le Duc G, Estève F, Bertrand B, Corde S, Farion R, Lefaix J L, Leplat J J, Berkvens P, Berruyer G, Brochard T, Dabin Y, Draperi A, Fiedler S, Nemoz C, Perez M, Renier M, Suortti P, Thomlinson W, Le Bas J F
Equipe d'Accueil Rayonnement Synchrotron et Recherche Médicale, Unité IRM, CHU, Grenoble, France.
Cell Mol Biol (Noisy-le-grand). 2000 Sep;46(6):1065-75.
We present in this paper two imaging techniques using contrast agents assessed with in vivo experiments. Both methods are based on the same physical principle, and were implemented at the European Synchrotron Radiation Facility medical beamline. The first one is intravenous coronary angiography using synchrotron radiation X-rays. This imaging technique has been planned for human studies in the near future. We describe the first experiments that were carried out with pigs at the ESRF. The second imaging mode is computed tomography using synchrotron radiation on rats bearing brain tumors. Owing to synchrotron radiation physical properties, these new imaging methods provide additional information compared to conventional techniques. After infusion of the contrast agent, it is possible to derive from the images the concentration of the contrast agent in the tumor area for the computed tomography and in any visible vessel for the angiography method.
我们在本文中介绍了两种使用造影剂并通过体内实验评估的成像技术。这两种方法基于相同的物理原理,且是在欧洲同步辐射装置的医学光束线上实现的。第一种是使用同步辐射X射线的静脉冠状动脉造影。这种成像技术计划在不久的将来用于人体研究。我们描述了在欧洲同步辐射装置上对猪进行的首次实验。第二种成像模式是对患有脑肿瘤的大鼠使用同步辐射进行计算机断层扫描。由于同步辐射的物理特性,这些新的成像方法与传统技术相比可提供更多信息。注入造影剂后,对于计算机断层扫描,可以从图像中得出肿瘤区域内造影剂的浓度,对于血管造影方法,则可以得出任何可见血管内造影剂的浓度。